These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37203066)

  • 1. Prevalence of hypertensive phase and outcomes in patients with Ahmed valve implantation at one year of follow-up and evaluation of associated risk factors.
    Neaves-Mendez J; Hernandez-Oteyza A; Alvarez-Ascencio D; Campos-Martinez G; Jimenez-Roman J
    Indian J Ophthalmol; 2023 May; 71(5):1966-1971. PubMed ID: 37203066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hypertensive phase after Ahmed glaucoma valve implantation.
    Özalp O; İlgüy S; Atalay E; Şimşek T; Yıldırım N
    Int Ophthalmol; 2022 Jan; 42(1):147-156. PubMed ID: 34420122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the hypertensive phase on the long-term outcomes of Ahmed glaucoma valve (AGV) implantation.
    Nilforushan N; Hassanpour K; Vafaei F; Yadgari M
    Int Ophthalmol; 2022 Dec; 42(12):3739-3747. PubMed ID: 35666338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of same-session trabectome surgery on Ahmed glaucoma valve outcomes.
    Esfandiari H; Shazly T; Shah P; Hassanpour K; Torkian P; Yaseri M; Loewen NA
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1509-1515. PubMed ID: 29602960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior versus inferior Ahmed glaucoma valve implantation.
    Pakravan M; Yazdani S; Shahabi C; Yaseri M
    Ophthalmology; 2009 Feb; 116(2):208-13. PubMed ID: 19062098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant.
    Kim TJ; Kang S; Jeoung JW; Kim YK; Park KH
    BMC Ophthalmol; 2018 Feb; 18(1):45. PubMed ID: 29444665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Ahmed glaucoma valve FP8 versus FP7 in adult secondary glaucoma.
    Ramyashri S; Raj N; Pradhan A; Ali MH; Rao A
    Int Ophthalmol; 2020 Jun; 40(6):1359-1366. PubMed ID: 32078134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term surgical outcomes of Ahmed valve implantation in refractory glaucoma according to the type of glaucoma.
    Kang YK; Shin JP; Kim DW
    BMC Ophthalmol; 2022 Jun; 22(1):270. PubMed ID: 35725417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Combined Ahmed Glaucoma Valve and Trabeculectomy Revision With Adjunctive Antimetabolite.
    Lin M; Alizadeh R; Law SK
    J Glaucoma; 2019 May; 28(5):404-410. PubMed ID: 31048638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ahmed glaucoma valve implantation with and without subconjunctival bevacizumab in refractory glaucoma.
    Zarei R; Ghasempour M; Fakhraie G; Eslami Y; Mohammadi M; Hamzeh N; Sajadi F; Safizadeh M
    Int Ophthalmol; 2021 May; 41(5):1593-1603. PubMed ID: 33564957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Vitrectomy-related Factors on the Outcome of Ahmed Glaucoma Valve Implantation.
    Jo J; Sung KR; Kim YJ
    Korean J Ophthalmol; 2018 Oct; 32(5):400-408. PubMed ID: 30311463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Outcomes of Combined Phacoemulsification and Ahmed Glaucoma Valve Implantation.
    Kwon J; Sung KR
    Korean J Ophthalmol; 2018 Jun; 32(3):211-220. PubMed ID: 29770636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive triamcinolone acetonide for Ahmed glaucoma valve implantation: a randomized clinical trial.
    Yazdani S; Doozandeh A; Pakravan M; Ownagh V; Yaseri M
    Eur J Ophthalmol; 2017 Jun; 27(4):411-416. PubMed ID: 27791254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Ahmed Glaucoma Valve Implantation on Neovascular Glaucoma.
    Xie Z; Liu H; Du M; Zhu M; Tighe S; Chen X; Yuan Z; Sun H
    Int J Med Sci; 2019; 16(10):1371-1376. PubMed ID: 31692923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ahmed glaucoma valve in various etiologies of refractory glaucoma: Surgical outcomes and success factors.
    Sahyoun MA; Farhat RG; Nehme JCB; Jalkh AE; Azar GG
    J Fr Ophtalmol; 2017 Nov; 40(9):770-776. PubMed ID: 29055728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas.
    Souza C; Tran DH; Loman J; Law SK; Coleman AL; Caprioli J
    Am J Ophthalmol; 2007 Dec; 144(6):893-900. PubMed ID: 17916318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ahmed glaucoma valve implantation with tube insertion through the ciliary sulcus in pseudophakic/aphakic eyes.
    Eslami Y; Mohammadi M; Fakhraie G; Zarei R; Moghimi S
    J Glaucoma; 2014 Feb; 23(2):115-8. PubMed ID: 22828010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcome of Intravitreal Bevacizumab Followed by Ahmed Valve Implantation in the Management of Neovascular Glaucoma.
    Tailor R; Kinsella MT; Clarke JC
    Semin Ophthalmol; 2018; 33(5):606-612. PubMed ID: 28992424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-Year Outcomes of Pars Plana Ahmed and Baerveldt Glaucoma Implantations for Neovascular Glaucoma in Japanese Eyes.
    Maeda M; Ueki M; Sugiyama T; Kohmoto R; Nemoto E; Kojima S; Ikeda T
    J Glaucoma; 2022 Jun; 31(6):462-467. PubMed ID: 34628430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Ahmed glaucoma valve and transscleral cyclophotocoagulation in neovascular glaucoma.
    Shalaby WS; Ganjei AY; Wogu B; Myers JS; Moster MR; Razeghinejad R; Lee D; Kolomeyer NN; Eid TE; Katz LJ; Shukla AG
    Indian J Ophthalmol; 2022 Apr; 70(4):1253-1259. PubMed ID: 35326027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.